|
|
News Breaks | | | | December 14, 2012 | | 07:12 EDT |  | CVS | CVS Caremark upgraded to Outperform from Neutral at Macquarie
Macquarie expects CVS Caremark's long-term growth to benefit from Healthcare reform laws and for shares to outperform based on limited 2013 negative earnings revisions, a stronger 2014 PBM selling season, and generics. Price target raised to $55 from $50. | |
|
News For CVS From The Last 14 Days Check below for free stories on CVS the last two weeks. |
|
|
| There are no results for CVS |
|
|
|
|
|
|
